source
- Over 200 biopharma investors urge EU governments to strengthen Europe's life-science sectorMore than 200 biopharma investors and companies have signed an open letter addressed to EU member states, calling for action to improve Europe's life‑science sector. The signatories argue that Eur…
- European regulators give second chance approval to Acadia’s Daybu for Rett syndromeEuropean Medicines Agency's CHMP has reversed its earlier negative vote and now recommends marketing authorization for Acadia Pharmaceuticals' drug Daybu (trofinetide) for Rett syndrome. The posit…